Peficitinib suppresses diffuse-type tenosynovial giant cell tumor by targeting TYK2 and JAK/STAT signaling

Shan Lu(Peking University), Yan Zhang(Dalian Medical University), Kaiping Liu(Peking University), Zhijun Wu(Peking University), Hongjie Huang(Peking University), Dingge Liu(Peking University), Erdan Dong(Qingdao University), Xin Zhang(Union Hospital), H. J. Yang(Qilu Hospital of Shandong University), Zhihua Zhang(Anhui Medical University), Haijun Wang(First Affiliated Hospital of Xinxiang Medical University), Jiayi Li(Peking University), Gang Yang(Peking University), Wenjia Zhang(Yunnan University), Hui Dai(Peking University), Chenxi Cao(Peking University), Yingjia Li(Nanfang Hospital), Xi Gong(Peking University), Yong‐Jian Wang(Peking University)
Science China Life Sciences
January 8, 2025
Cited by 5


Related Papers